Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Curr Pharm Des
2022 Jan 01;2846:3671-3676. doi: 10.2174/1381612829666221207093215.
Show Gene links
Show Anatomy links
Therapeutic Applications of Fucoidans and their Potential to Act Against COVID-19.
Yadav D
,
Song M
.
???displayArticle.abstract???
In this review article, we present the updated evidence of therapeutic applications of fucoidan (a seaweed polysaccharide) and its novel potential to treat infectious diseases such as coronavirus disease (COVID-19). Because of their many biological activities, seaweeds have been identified as a rich and useful source of bioactive chemicals. Sulfated polysaccharides from the sea are considered a source of physiologically active chemicals that might be used in medication development. Antitumor, antiviral, antioxidant, antibacterial, anticoagulant, and immune-inflammatory properties have all been described for these compounds. By interfering at various phases of viral infection, marine sulfated polysaccharide has a virucidal effect. As a result, it opens the door to the development of antiviral treatments. Virus entry into host cells is an initial process, avoiding this type of entry makes any precautionary measure effective. The inhibitory action of certain marine sulfated polysaccharides against coronavirus was tested, and fucoidan, iota-carrageenan, and sea cucumber sulfated polysaccharides all showed a substantial antiviral impact. Fucoidan is one of the useful sulfated polysaccharides that has been widely studied and explored in various research. There are different sources of fucoidans, which have been used in the treatment of viral infection. Additionally, we highlight the mechanism of action of fuocidan against COVID-19. Hence, we could suggest that COVID-19 might be prevented and treated using these sulfated polysaccharides. This review thus highlights ample evidence to support the hypothesis that a large number of drugs have been developed from powerful compounds isolated from marine seaweeds.
Anand,
A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery.
2019, Pubmed
Anand,
A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery.
2019,
Pubmed
Ao,
Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry.
2021,
Pubmed
Arokiarajan,
Advance research in biomedical applications on marine sulfated polysaccharide.
2022,
Pubmed
Ayatollahi,
Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.
2021,
Pubmed
Bittkau,
Comparison of the Effects of Fucoidans on the Cell Viability of Tumor and Non-Tumor Cell Lines.
2019,
Pubmed
Cao,
Antiviral activity of polysaccharide extract from Laminaria japonica against respiratory syncytial virus.
2016,
Pubmed
Chaisuwan,
The Antiviral Activity of Bacterial, Fungal, and Algal Polysaccharides as Bioactive Ingredients: Potential Uses for Enhancing Immune Systems and Preventing Viruses.
2021,
Pubmed
Chauhan,
The Therapeutic Potential of Algal Nanoparticles: A Brief Review.
2022,
Pubmed
Chauhan,
Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19.
2021,
Pubmed
Chavda,
Mini-Review on SARS-CoV-2 Infection and Neurological Manifestations: A Perspective.
2022,
Pubmed
Chen,
Characterization of polysaccharides from different species of brown seaweed using saccharide mapping and chromatographic analysis.
2021,
Pubmed
Conti,
Identification of Drug Interaction Adverse Events in Patients With COVID-19: A Systematic Review.
2022,
Pubmed
David,
Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
2021,
Pubmed
De Pasquale,
Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2.
2021,
Pubmed
Dinesh,
In vitro anti-HIV-1 activity of fucoidan from Sargassum swartzii.
2016,
Pubmed
Fitton,
Therapies from Fucoidan: New Developments.
2019,
Pubmed
Giossi,
A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients.
2021,
Pubmed
Gozzo,
The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review.
2020,
Pubmed
Hans,
Antiviral activity of sulfated polysaccharides from marine algae and its application in combating COVID-19: Mini review.
2021,
Pubmed
Hu,
Characteristics of SARS-CoV-2 and COVID-19.
2021,
Pubmed
Jin,
The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles.
2021,
Pubmed
Jin,
The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica.
2020,
Pubmed
Katare,
Lipid-lowering and antioxidant functions of bottle gourd (Lagenaria siceraria) extract in human dyslipidemia.
2014,
Pubmed
Khanna,
Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle.
2021,
Pubmed
Krylova,
The Comparative Analysis of Antiviral Activity of Native and Modified Fucoidans from Brown Algae Fucus evanescens In Vitro and In Vivo.
2020,
Pubmed
Kuznetsova,
Immunoadjuvant Activity of Fucoidans from the Brown Alga Fucus evanescens.
2020,
Pubmed
Kwon,
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro.
2020,
Pubmed
Li,
Fucoidan: structure and bioactivity.
2008,
Pubmed
Lim,
Medicinal Plants in COVID-19: Potential and Limitations.
2021,
Pubmed
Luthuli,
Therapeutic Effects of Fucoidan: A Review on Recent Studies.
2019,
Pubmed
Mak,
Fucoidan from New Zealand Undaria pinnatifida: monthly variations and determination of antioxidant activities.
2013,
Pubmed
Maurya,
Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection.
2022,
Pubmed
Mirzaie,
A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19).
2020,
Pubmed
Moscona,
Global transmission of oseltamivir-resistant influenza.
2009,
Pubmed
Muthu,
Medicinal plants used by traditional healers in Kancheepuram district of Tamil Nadu, India.
2006,
Pubmed
Negishi,
Supplementation of elderly Japanese men and women with fucoidan from seaweed increases immune responses to seasonal influenza vaccination.
2013,
Pubmed
Paine,
Natural Products: Experimental Approaches to Elucidate Disposition Mechanisms and Predict Pharmacokinetic Drug Interactions.
2020,
Pubmed
Panther,
Subarachnoid hemorrhage: management considerations for COVID-19.
2022,
Pubmed
Pereira,
The COVID 19 novel coronavirus pandemic 2020: seaweeds to the rescue? Why does substantial, supporting research about the antiviral properties of seaweed polysaccharides seem to go unrecognized by the pharmaceutical community in these desperate times?
2020,
Pubmed
Ponce,
A Comprehensive and Comparative Analysis of the Fucoidan Compositional Data Across the Phaeophyceae.
2020,
Pubmed
Prokofjeva,
Fucoidans as potential inhibitors of HIV-1.
2013,
Pubmed
Richards,
Oral Fucoidan Attenuates Lung Pathology and Clinical Signs in a Severe Influenza a Mouse Model.
2020,
Pubmed
Ruocco,
Polysaccharides from the Marine Environment with Pharmacological, Cosmeceutical and Nutraceutical Potential.
2016,
Pubmed
Sanjeewa,
Fucoidans as Scientifically and Commercially Important Algal Polysaccharides.
2021,
Pubmed
Sanniyasi,
In vitro anti-HIV-1 activity of the bioactive compound extracted and purified from two different marine macroalgae (seaweeds) (Dictyota bartayesiana J.V.Lamouroux and Turbinaria decurrens Bory).
2019,
Pubmed
Sen,
Revival, modernization and integration of Indian traditional herbal medicine in clinical practice: Importance, challenges and future.
2017,
Pubmed
Shereen,
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.
2020,
Pubmed
Small,
Coronavirus Disease-2019 and Stroke: Pathophysiology and Management.
2023,
Pubmed
Song,
Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2.
2020,
Pubmed
,
Echinobase
Song,
Structural characterization and antitumor effects of fucoidans from brown algae Kjellmaniella crassifolia farmed in northern China.
2018,
Pubmed
Synytsya,
Mekabu fucoidan: structural complexity and defensive effects against avian influenza A viruses.
2014,
Pubmed
Sytar,
COVID-19 Prophylaxis Efforts Based on Natural Antiviral Plant Extracts and Their Compounds.
2021,
Pubmed
Talsma,
MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides.
2020,
Pubmed
Thakur,
Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations.
2021,
Pubmed
Ti,
Progress of Plant Medicine Derived Extracts and Alkaloids on Modulating Viral Infections and Inflammation.
2021,
Pubmed
Tiwari,
In vitro antiviral activity of neem (Azardirachta indica L.) bark extract against herpes simplex virus type-1 infection.
2010,
Pubmed
Verdecchia,
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
2020,
Pubmed
Wang,
Synthesized different derivatives of low molecular fucoidan extracted from Laminaria japonica and their potential antioxidant activity in vitro.
2009,
Pubmed
Wang,
Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway.
2017,
Pubmed
Wang,
Antiviral activity of puerarin as potent inhibitor of influenza virus neuraminidase.
2021,
Pubmed
Yang,
Fucoidans and Bowel Health.
2021,
Pubmed
Yu,
Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic.
2020,
Pubmed
Zhang,
Ecklonia cava fucoidan has potential to stimulate natural killer cells in vivo.
2021,
Pubmed